MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. MTD
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Mettler-Toledo International, I (MTD) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NYSE•Healthcare•Diagnostics & Research
C
AverageMetricSide Score: 54/100
ProfitabilityProfit20/30
GrowthGrowth15/25
Balance SheetBalance8/25
Cash QualityCash11/20
Price & Volume
Market Cap $26.54B

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

Moat Signals

Competitive analysis based on 57 quarters of fundamental data

Pricing Power

Strong Moat

Operating margins are stable at ~25.5%, suggesting durable pricing power and cost discipline.

Competitive Advantage

Moderate Moat

Limited ROE data for a reliable assessment.

Cash Generation

Moderate Moat

7 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.

Demand Durability

Weak Moat

Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.

Risk Signals

Data-driven red flags and warnings across 57 quarters

Some Concerns

Margin Pressure

Healthy

Margins are stable or improving at ~25.7% — no sign of cost or pricing stress.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Leverage Risk

Healthy

Limited debt-to-equity data available.

Revenue Decline

Red Flag

TTM revenue has contracted 25.7% — significant decline indicating deteriorating demand.

Cash Burn

Healthy

Free cash flow is consistently positive — the business self-funds without external capital reliance.

Share Dilution

Healthy

Shares decreased 7.1% — net buybacks are reducing shares outstanding and boosting per-share value.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$6.02B
6.1%
Q. Revenue
$947.13M
TTM EBITDA
$1.65B
10.0%
TTM Op. Income
$1.55B
7.6%
Q. Op. Income
$202.33M
TTM Net Income
$1.29B
7.8%
Q. Net Income
$169.45M
EPS
$8.35
Shares Out.
$20.29M
4.0%
$6.02B in TTM revenue grew 6.1% YoY, reaching $947.13M last quarter. TTM EBITDA of $1.65B and TTM operating income of $1.55B shows growth is flowing through. Net income of $1.29B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
58.7%
2.1%
EBITDA Margin
22.8%
Op. Margin
21.4%
20.7%
Net Margin
17.9%
19.3%
Op. margin of 21.4% is down 5.6% YoY — costs are rising relative to revenue. Net margin at 17.9% and gross margin of 58.7% — earnings take a bigger bite when COGS stays lean..

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
20.6x
P/S Ratio
4.4x
P/B Ratio
N/A
At 20.6x P/E, the stock trades in line with market averages — fairly valued. P/S of 4.4x and P/B of 0.0x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$3.67B
Cash
$60.57M
Long-Term Debt
$2.16B
Book Value
$-41.88M
D/E Ratio
N/A
Debt/EBITDA
10.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$139.79M
Free Cash Flow
$122.38M
51.0%
FCF Margin
2.0%
FCF / Net Income
0.7
FCF of $122.38M on $139.79M in operating cash flow. The FCF / Net Income ratio of 0.1x indicates partial cash conversion — earnings quality needs attention.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors